NCT00404820
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
- Locations
-
- For site information contact Novartis Pharmaceuticals Multiple Cities, Germany
Clinical trial condition
Osteoporosis
Explore clinical trials studying Osteoporosis. Study availability and eligibility vary by location and protocol.
926 public trials
76 recruiting studies
Osteoporosis trial results
NCT00320567
- Conditions
- Anorexia Nervosa, Bone Diseases, Bone Diseases, Metabolic, +6 more
- Locations
-
Not specified
NCT00145327
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
- Locations
-
- Southern Arizona VA Tucson, Arizona, United States
- University of Arkansas for Medical Science Little Rock, Arkansas, United States
- Osteoporosis Medical Center Beverly Hills, California, United States
- Osteoporosis Prevention Center San Diego, California, United States
NCT00761332
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pokfulam, Hong Kong
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ahmedabad, India
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gurgaon, India
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyderabaad, India
Completed
Does Bone Structure Explain the Increased Fracture Risk in Type II Diabetes Patients? A Pilot Study
NCT00703417
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Diabetes Mellitus, +6 more
- Locations
-
- China Basin Imaging Center San Francisco, California, United States
NCT01112098
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT00696644
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
- For additional information regarding investigative sites for this study, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valeggio sul Mincio, Verona, Italy
NCT00697983
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
- Locations
-
- Maastricht University Medical Center Maastricht, Limburg, Netherlands
NCT01130428
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
- Locations
-
- Maastricht University Medical Center Maastricht, Netherlands
Completed
Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis
NCT00439244
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
- Locations
-
- Birmingham, Alabama, United States
- Beverly Hills, California, United States
- Novartis Investigative Site La Mesa, California, United States
- Novartis Investigative Site Oakland, California, United States